About TFChem
TFChem is a company based in Rouen (France) founded in 2007.. TFChem operates in a competitive market with competitors including GlyTech, Iceni Glycoscience, Echelon Biosciences, Avanti Polar Lipids and GlycoSpot, among others.
- Headquarter Rouen, France
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
CNRS
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of TFChem
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
- First Round First Round
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2022 | Amount | Grant - TFChem | Valuation |
investors |
|
| Jun, 2012 | Amount | Grant - TFChem | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in TFChem
TFChem has secured backing from 5 investors, including institutional investors. Prominent investors backing the company include CNRS, University of Rouen Normandie and INSA Rouen Normandy. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Multiple courses and degrees are offered in diversified academic streams.
|
Founded Year | Domain | Location | |
|
Engineering courses are delivered by INSA Rouen Normandy center.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by TFChem
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - TFChem
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Tfchem Comparisons
Competitors of TFChem
TFChem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GlyTech, Iceni Glycoscience, Echelon Biosciences, Avanti Polar Lipids and GlycoSpot, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Human-type Asp-linked glycans are supplied for research applications.
|
|
| domain | founded_year | HQ Location |
Glycoscience platform is provided for diagnostic and therapeutic applications.
|
|
| domain | founded_year | HQ Location |
Reagents and assays for lipid biology research are manufactured.
|
|
| domain | founded_year | HQ Location |
Phospholipids and lipids are manufactured for life science applications.
|
|
| domain | founded_year | HQ Location |
High-throughput enzyme screening solutions are developed and provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about TFChem
When was TFChem founded?
TFChem was founded in 2007 and raised its 1st funding round 5 years after it was founded.
Where is TFChem located?
TFChem is headquartered in Rouen, France. It is registered at Rouen, Normandie, France.
What does TFChem do?
TFChem was established in 2007 in Rouen, France, as a drug discovery entity within the biotechnology sector. Fluoride-modified carbohydrate compounds are developed for therapeutics addressing cancer, diabetes, cardiovascular diseases, pain, and inflammation. The GlycoMim platform is employed to enhance stability, bioavailability, and selectivity of these molecules. Collaborations with pharmaceutical firms are pursued for candidate advancement, while internal programs are operated. The company functions as a subsidiary of Sirona Biochem Corp.
Who are the top competitors of TFChem?
TFChem's top competitors include GlyTech, Echelon Biosciences and Iceni Glycoscience.
Who are TFChem's investors?
TFChem has 5 investors. Key investors include CNRS, University of Rouen Normandie, INSA Rouen Normandy, Government of France, and Ministry of Economy, Finance and Industrial and Digital Sovereignty.